Skip to main navigation

How Urovant Sciences is Responding to COVID-19

Learn More
clear
Home
Home

Main navigation

  • About
  • Science
  • Patients
  • News & Media
    • Corporate Overview
    • News Releases
    • Events & Presentations
    • Corporate Policies
    • FAQs
    • Contact Corporate Communications
  • Careers
  • Contact

Urovant Sciences is advancing urologic patient care by delivering and developing innovative therapies.

 

Urovant Sciences is a biopharmaceutical company advancing urologic patient care through development of innovative therapies and exceptional licensing opportunities.

Our goal is to be the leading specialty company, recognized and trusted by patients and providers for our commitment to urology and their well-being. Urologic conditions can have a major impact on daily life, with those affected often suffering in silence as their conditions are overlooked, misunderstood or not adequately treated. 

More than 30 million people in the U.S. live with the bothersome symptoms of overactive bladder (OAB). The FDA has recently approved Gemtesa® (vibegron) for the treatment of overactive bladder in adult patients.

Click here for more information.

Urovant Sciences is investigating vibegron, a ß3 adrenergic agonist, for the treatment of OAB in men with benign prostatic hyperplasia, and URO-902, a novel gene therapy, for the treatment of OAB. 

 
In The News

View All
April 15, 2021
Urovant Sciences Announces Publication of Positive Long-Term Clinical Safety and Efficacy Data on the FDA-Approved Overactive Bladder Therapy, GEMTESA® (vibegron), in the Journal of Urology
View Press Release
April 12, 2021
Urovant Sciences Announces U.S. Commercial Launch of GEMTESA® (vibegron) 75 mg Tablets for Patients with Overactive Bladder
View Press Release
February 12, 2021
Urovant Sciences Provides Merger Update and Reports Third Quarter Fiscal Year 2020 Results
View Press Release
Urovant Sciences Logo

Footer menu

To report an Adverse Event or Product Complaint, call 1-833-876-8268

Legal

  • Terms of Use
  • Privacy Policy
  • Community Guidelines
UROVANT, UROVANT SCIENCES, the UROVANT SCIENCES logo, GEMTESA, and the GEMTESA logo are trademarks of Urovant Sciences GmbH, registered in the U.S. and in other countries. All other trademarks are the property of their respective owners. © 2021 Urovant Sciences GmbH. All rights reserved.
US-UROV-2000082 (v5.0)